10x Genomics Inc (NAS:TXG)
$ 24.83 -0.18 (-0.72%) Market Cap: 2.97 Bil Enterprise Value: 2.71 Bil PE Ratio: 0 PB Ratio: 4.13 GF Score: 76/100

10X Genomics Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 02:35PM GMT
Release Date Price: $32.96 (-10.58%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Hey, everyone. Good morning. My name is Tejas Savant, I'm the life science tools and diagnostics analyst at Morgan Stanley. It's my pleasure to host 10x Genomics this morning. And with us, we have Serge Saxonov, CEO; and Justin McAnear, our CFO. Thanks gents, for being here. Before we get started, just need to rattle off the disclosure statement. Please see the Morgan Stanley research website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your sales rep.

Questions & Answers

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

So with that, Serge, before we begin, could you just take a couple of minutes to just talk us through where the business is today, some of the challenges you've encountered over the last few months? And what are you most excited about looking to 2023?

Serge Saxonov
10x Genomics, Inc. - Co-Founder, CEO & Director

So in terms of -- so kind of stepping

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot